Professor Andrew Scott is a leading medical specialist, with comprehensive experience in nuclear medicine and Positron Emission Tomography (PET), and in cancer biology.
Professor Scott current positions include Director of the Department of Molecular Imaging and Therapy at Austin Health, Laboratory Head at the Olivia Newton-John Cancer Research Institute, Professor in the School of Cancer Medicine at La Trobe University, and Professor in Faculty of Medicine at the University of Melbourne.
Professor Scott holds a Bachelor of Medicine/Bachelor of Surgery (Honours) and a Doctor of Medicine from the University of Sydney. He trained in Internal Medicine, Nuclear Medicine and Tumour Immunology in Sydney, and at the Memorial Sloan-Kettering Cancer Center, USA, before returning to Australia to pursue his clinical and research career.
He has published over 320 peer-reviewed papers and 22 book chapters, principally in oncology and molecular imaging. Invited reviews in leading journals include Nature Reviews Cancer and Cancer Research. He is on the Editorial Boards of many high-ranking oncology and nuclear medicine journals.
Professor Scott is a Fellow of the Australian Academy of Health and Medical Sciences, Fellow of the Australian Association of Nuclear Medicine Specialists, and Fellow of the Australian Institute of Company Directors. He is Chair of the Board of Cancer Trials Australia and on the Executive Board of the World Federation of Nuclear Medicine and Biology.
In 2017 Professor Scott was awarded Member (AM) in the General Division of the Order of Australia.
Professor Scott is a member of the Risk & Audit Committee.
Appointed: 26 September 2007
Reappointed: 29 September 2011
Reappointed: 29 September 2016
Term concludes: 28 September 2021